Figure 1.
SLPs of C. difficile induced inflammasome activation. (A) SLPs were isolated from non-toxigenic C. difficile (tcdA−, tcdB−), followed by (A) SDS-PAGE and (B) western blot assays. Purified SLPs possess high molecular weight (HMW) and low molecular weight (LMW) components. M, protein markers with molecular weights in kDa. The production of matured caspase-1 and IL-1β were increased by SLP treatment as well as C. difficile infection (C), and in a dose-dependent manner (D). (E) Matured caspase-1 and IL-1β were blockaded by anti-SLP Abs.